Akhteruzzaman Molla - Concepedia

Author

Akhteruzzaman Molla

Also Known As

A Molla, A. H. M. Shofiul Islam Molla, A. MOLLA, A. Molla, Akhteruzzaman MOLLA, Akhteruzzaman Molla, Anirban Molla, Molla, Akhteruzzaman

101

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Kumamoto University Abbott (United Kingdom)Abbott (United States)Stony Brook University

About

Akhteruzzaman Molla is an author at Abbott Fund specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	62	4.7K
2	Natural Sciences	18	20	1.9K
3	Health Sciences	2	2	72
4	Education	1	1	18
5	Engineering	1	1	31

Akhteruzzaman Molla

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir Akhteruzzaman Molla, Marina Korneyeva, Qing Gao, Nature Medicine Viral ReplicationOrdered AccumulationNatural SciencesHuman RetrovirusPathogenesis	1996	766
Cell-Free, De Novo Synthesis of Poliovirus Akhteruzzaman Molla, Aniko V. Paul, Eckard Wimmer Science Cell-based Vaccine ProductionPoliovirus RnaViral ReplicationMolecular VirologySynthetic Virology	1991	372
The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir Dale J. Kempf, Richard A. Rode, Yi Xu, AIDS	1998	224
Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy Dale J. Kempf, Hing L. Sham, Kennan C. Marsh, Journal of Medicinal Chemistry ImmunologyPharmacotherapyAntiviral DrugPharmaceutical ChemistryDrug Resistance	1998	204
Activation of Hageman Factor and Prekallikrein and Generation of Kinin by Various Microbial Proteinases Akhteruzzaman Molla, Toshio Yamamoto, Takaaki Akaike, Journal of Biological Chemistry Laboratory ImmunologyImmunologyHageman FactorProtein PurificationInflammation	1989	194
Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects Ann Hsu, G. Richard Granneman, Galen Witt, Antimicrobial Agents and Chemotherapy PharmacologyImmunologyAntiviral TherapyVirologyPharmacotherapy	1997	186
Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus Akhteruzzaman Molla, Sudthida Vasavanonda, Gondi Kumar, Virology Protease InhibitorsBiochemistryMedicineNatural SciencesHuman Retrovirus	1998	177
In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants with Increased Resistance to ABT-378, a Novel Protease Inhibitor Alejandro Vicente‐Carrillo, Kent D. Stewart, Hing L. Sham, Journal of Virology Human RetrovirusResistant Hiv-1ImmunologyAntiviral ResponseMolecular Biology	1998	171
Mutations Conferring Resistance to a Potent Hepatitis C Virus Serine Protease Inhibitor In Vitro Liangjun Lu, Kent D. Stewart, John T. Randolph, Antimicrobial Agents and Chemotherapy ImmunologyMolecular BiologyPathologyAntiviral DrugHcv Replicons	2004	164
<i>In Vitro</i> and <i>In Vivo</i> Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A Preethi Krishnan, Jill Beyer, Neeta Mistry, Antimicrobial Agents and Chemotherapy	2014	130

Page 1